Author:
Lamon-Fava Stefania,Schaefer Ernst J.
Reference53 articles.
1. Havel RJ, Kane JP. “Introduction: structure and metabolism of plasma lipoproteins.” In The metabolic and molecular bases of inherited disease, Scriver CR, Beaudet AL, Sly WS, Valle D, eds. New York, NY: McGraw-Hill, 1995.
2. Schaefer EJ, Seman LJ. “The diagnosis and management of lipoprotein disorders.” In Medical management of diabetes mellitus, Leahy JL, Clark NG, Cefalu WT, eds. New York, NY: Marcel-Dekker, 2000.
3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report on the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497.
4. Criqui M, Heiss G, Cohn R, Cowan LD, Suchindran CM, Bangdiwala S, Kritchevsky S, Jacobs DR, Kim O’Grady H, Davis CE. Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med. 1993;328:1220–1225.
5. Hokanson JE, Austin MA. Plasma triglyceride level as a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996;3:213–219.